1-4 of 4
Drew Torigian, MD
Close
Sort by
Journal Articles

Dual Time Point FDG-PET/CT Imaging Can Distinguish Between Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma

Elise A. Chong, MD, Drew Torigian, MD, Jakub Svoboda, MD, Sunita Dwivedy Nasta, MD, Abass Alavi, MD, Stephen J. Schuster, MD
Journal: Blood
Blood (2014) 124 (21): 1613.
https://doi.org/10.1182/blood.V124.21.1613.1613
Published: 2014
Journal Articles

The Role Of PET Imaging For Predicting Treatment Failure In Primary Mediastinal B-Cell Lymphoma

Sarah J. Nagle, MD, Elise A. Chong, MD, Seble Chekol, MD, Nirav N. Shah, MD, Sunita D. Nasta, MD, Eli Glatstein, MD, John P. Plastaras, MD PhD, Drew Torigian, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD
Journal: Blood
Blood (2013) 122 (21): 4302.
https://doi.org/10.1182/blood.V122.21.4302.4302
Published: 2013
Journal Articles

Maximum Standard Uptake Value (SUVmax) on FDG-PET Imaging Predicts Time to First Treatment in Patients with Low Grade Follicular Lymphoma,

Jakub Svoboda, MD, Elise A. Chong, BA, Emeline R Chong, Sunita D. Nasta, MD, Drew Torigian, MD, Abass Alavi, MD, Stephen J. Schuster, MD
Journal: Blood
Blood (2011) 118 (21): 4204.
https://doi.org/10.1182/blood.V118.21.4204.4204
Published: 2011
Journal Articles

Post-Treatment (not interim) PET-CT Scan Status Is Highly Predictive of Outcome In Mantle Cell Lymphoma Treated with R-Hypercvad or ASCT

Anthony R Mato, MD, Tania Zielonka, Tatyana Feldman, MD, Jakub Svoboda, MD, Harry Agress, MD, David Panush, MD, Mitchell Miller, MD, Patrick Toth, MD, Elise A Chong, BA, Emeline R Chong, Drew Torigian, MD, Paul M Lizott, Jr., RT, Stephen J. Schuster, MD, Scott D Rowley, MD, Michele L Donato, MD, Stuart L Goldberg, MD, Andrew L Pecora, MD, Andre Goy, MD
Journal: Blood
Blood (2010) 116 (21): 3131.
https://doi.org/10.1182/blood.V116.21.3131.3131
Published: 2010